Deslauriers, Frédérique http://orcid.org/0000-0002-1900-0321
Léger, Camille http://orcid.org/0009-0004-3672-1616
Bacon, Simon L. http://orcid.org/0000-0001-7075-0358
Lavoie, Kim L. http://orcid.org/0000-0003-2606-1357
,
Funding for this research was provided by:
Centre interuniversitaire de recherche sur les reseaux d'entreprise, la logistique et le transport (#MM1-174903)
Canadian Institutes of Health Research (MM1-1749903, SMC-151518, PJT-479128, CGS-M)
Fonds de Recherche du Québec - Santé (251618, 34757)
Fonds de Recherche du Québec-Société et Culture (2019-SE1-252541)
Canada Research Chairs (950-232522)
Ministère de l'Économie, de l’Innovation et des Exportations du Québec (2020-2022-COVID-19-PSOv2a-51754)
Article History
Received: 30 May 2023
Accepted: 15 June 2023
First Online: 11 August 2023
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (Research Ethics Committee at the Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l’Île-de-Montréal (CIUSSS-NIM) [REB#: 2020–2099/03–25-2020]) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Subjects’ consent was waived due to the non-identifiable nature of the data that were collected.
: Dr. Lavoie is a member of the Canadian COVID-19 Expert Advisory Panel (Health Canada). She has served on the advisory board or as a consultant for Schering-Plough, Takeda, AbbVie, Almirall, Janssen, GlaxoSmithKline (GSK), Novartis, Boehringer Ingelheim (BI), Respiplus, and Sojecci Inc., has received sponsorship for investigator-generated research grants from GSK and AbbVie, and speaker fees from GSK, Astra-Zeneca, Astellas, Novartis, Takeda, AbbVie, Merck, BI, Bayer, Pfizer, Xfacto, Respiplus, and Air Liquide, and has received support for educational materials from Merck, none of which are related to the current article. Dr. Bacon is a member of the Health Canada COVID Alert Application Working Group. He has served on the advisory board for Bayer and Sanofi, has received sponsorship for investigator-generated research grants from GSK, Moderna, and Abbvie, consultation fees from Schering-Plough, Merck, Astra Zeneca, Sygesa, Bayer, Sanofi, Lucilab, and Respiplus, and speaker fees from Novartis, Respiplus, and Janssen, none of which are related to the current article. The remaining authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.